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Abstract
Background: The transforming growth factor beta is known to have pleiotropic effects, including
differentiation, proliferation and apoptosis. However the underlying mechanisms remain poorly
understood. The regulation and effect of TGF-β signaling is complex and highly depends on specific
protein context. In liver, we have recently showed that the disintegrin and metalloproteinase
ADAM12 interacts with TGF-β receptors and modulates their trafficking among membranes, a
crucial point in TGF-β signaling and development of fibrosis. The present study aims to better
understand how ADAM12 impacts on TGF-β receptors trafficking and TGF-β signaling.
Findings: We extracted qualitative biological observations from experimental data and defined a
family of models producing a behavior compatible with the presence of ADAM12. We
computationally explored the properties of this family of models which allowed us to make novel
predictions. We predict that ADAM12 increases TGF-β receptors internalization rate between the
cell surface and the endosomal membrane. It also appears that ADAM12 modifies TGF-β signaling
shape favoring a permanent response by removing the transient component observed under
physiological conditions.
Conclusion: In this work, confronting differential models with qualitative biological observations,
we obtained predictions giving new insights into the role of ADAM12 in TGF-β signaling and hepatic
fibrosis process.
Background
During chronic liver injury, the sustained wound healing
response leads to fibrosis and cirrhosis. Among the molec-
ular components involved in fibrogenesis, the transform-
ing growth factor, TGF-β is the most potent profibrotic
cytokine. Indeed, several authors have shown that altera-
tion of TGF-β dependent signaling pathway is associated
with liver fibrosis [1,2]. In this system, the first cellular
control point is at the membrane. TGF-β transmits its sig-
nal through a heteromeric complex of two types of trans-
membrane receptors, TβRI and TβRII. TGF-β binding to
TβRII induces recruitment and phosphorylation of TβRI,
which activates R-Smad intracellular signaling [3]. At the
membrane, an important feature of TGF-β signaling is the
continuous internalization of receptors and ligand-recep-
tor complexes through two endocytosis pathways: the
clathrin-coated pit endocytosis, mediating R-Smad signal-
ing cascade, and the caveolin mediated endocytosis, lead-
ing to degradation of receptors through the proteasome
pathway [4,5].
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We have recently demonstrated that ADAM12, a member
of the disintegrin and metalloproteinase family associated
with liver fibrogenesis [6,7], facilitates TGF-β signaling at
the membrane [8]. ADAM12 interacts with TβRII and
enhances TGF-β activity by modulating TGF-β  receptor
trafficking. In order to understand how ADAM12 expres-
sion might affect TGF-β signaling activity, we investigated
mathematical models for ADAM12-dependent TGF-β sig-
naling pathways. Based on models describing physiologi-
cal TGF-β receptor trafficking and using a fitting procedure
based on biological qualitative observations, we com-
puted a family of models mimicking the pathological traf-
ficking involving ADAM12. Their analysis allowed us to
predict new effects of ADAM12 on TGF-β signaling.
Results
Mathematical models of TGF-β receptor trafficking
Based on two published works by Vilar et al. [9] and Zi et
al. [10], we elaborated two differential models handling
the trafficking of TGF-β receptors in membranes. We gath-
ered the common components of Vilar et al. and Zi et al.
models while putting the stress on their differences. We
refer to them as V-model and Z-model for the models
based upon Vilar et al. and Zi et al., respectively. The fol-
lowing paragraphs describe their characteristics. Table 1
and Table 2 provide a list of abbreviations and kinetic
coefficients values.
Receptors and ligand
TβRI and TβRII are considered as a single receptor com-
plex (named R) since the two receptors have been
reported to traffic complexed together. At the cell surface
membrane and upon TGF-β stimulation this complex can
form a ligand-receptor complex (LRC). We note that
homomeric TβRII complexes have been reported to bind
TGF-β, however they have not shown any direct role in
signaling [11] and are thus eluded.
Localizations
Receptors and LRCs can be present at the cell surface
membrane and in internal membranes. There is a con-
stant trafficking between those compartments which is
unaffected by the presence of TGF-β. Internalization and
recycling routes exist between the cell surface membrane
and two inner compartments, the endosome (kie, kre) and
the caveosome (kic, krc).
Production and degradation of receptors
Constitutive production of receptors toward the cell sur-
face membrane (pR) is balanced by constitutive degrada-
tion (kcd), equally affecting receptors and LRCs. LRCs
present in the caveosome undergo a ligand-induced deg-
radation (klid). Constitutive degradation happens either at
the cell surface (V-model) or in the endosome (Z-model).
Signal transmission
Signal transmission to downstream components of the
TGF-β pathway is mediated through LRC association with
R-Smads in the endosomal compartment. According to
[9], TGF-β signaling is assumed to be proportional to the
amount of LRCs internalized in the endosome.
The kinetic coefficients of our two models were deter-
mined using experimental measurements [5,12,13]. Dia-
grammatic representations and equations are provided in
Figure 1.
Our first analysis was to compare the behaviors of our two
models. We investigated the evolution of LRCs accumu-
lated in the endosome upon TGF-β  stimulation. The
results are shown in Figure 2. We observe that quickly
after the beginning of the stimulation, the signal raises to
a high value (transient component) before decreasing to a
lower stable state (permanent component). Those two
models, producing very comparable behaviors, represent
the physiological response of cells to TGF-β, in which
ADAM12 is absent.
Qualitative fitting procedure
Our biological data [8] suggest that, whether ADAM12 is
present or not, receptors keep trafficking among the same
compartments and are subject to the same degradation
processes. We thus made the hypothesis that ADAM12
does not modify the structure of the receptor trafficking,
but rather modulates the involved kinetic coefficients.
The biological data on the effect of ADAM12 are qualita-
tive and can thus be translated into constraints that a sys-
tem with ADAM12 should fulfill. We report in Table 3 the
Table 1: List of abbreviations
abbreviation definition
pR Receptors production rate
kie Internalization rate towards endosome
Kre Recycling rate from endosome
kic Internalization rate towards caveosome
Krc Recycling rate from caveosome
kcd Constitutive degradation rate
klid Ligand induced degradation rate
ka LRC formation rate
LRC Ligand-receptor complex
Rm Receptor complexes in the cell membrane
Re Receptor complexes in the endosome
Rc Receptor complexes in the caveosome
LRCm LRCs at the cell surface membrane
LRCe LRCs in the endosome
LRCC LRCs in the caveosome
CIR Constitutive to Induced degradation RatioBMC Research Notes 2009, 2:193 http://www.biomedcentral.com/1756-0500/2/193
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biological observations on ADAM12 used in this work,
along with their mathematical translation.
We implemented a heuristic search of fitting kinetic coef-
ficients and an exploration of the set of fitting coefficients.
All kinetic coefficients except pR and ka undergo fitting. pR
is eluded because receptor production is not significantly
affected by ADAM12 and TGF-β  stimulation (personal
data). ka is circumvented because the formation of LRC is
considered instantaneous when compared to receptor
trafficking. The algorithm outputs a family of models that
fits the biological data obtained in presence of ADAM12
(as exemplified in Figure 3). Models within this family
only differ from V-model and Z-model by their kinetic
coefficients.
ADAM12 increases internalization from cell surface to 
endosome
The algorithm draws kinetic coefficient lines between
valid (according to experimental data) and non-valid
models (Figure 4). The possible kinetic coefficients for the
models fitting the effect of ADAM12 are rather similar,
whether they have the architecture of V-model or Z-
model.
The algorithm allows all coefficient multipliers to range
from 0.1 to 10. While most coefficients present this dis-
persion, 3 are more tightly constrained. They are kie, kre
and kcd.
To take ADAM12 effect into account, the recycling rate
from endosome to cell surface (kre) is allowed to decrease
(up to 0.69 times the physiological coefficient for V-
model, 0.66 for Z-model) or to increase (up to 3.08 for V-
model, 3.56 for Z-model). The constitutive degradation
(kcd) has to decrease for Z-model solutions (maximal mul-
tiplier: 0.33). The only coefficient that follows the same
trend, in every solution, is the internalization towards the
endosome (kie), it has to increase by at least a factor 2.14
or 2.05 for V-model or Z-model architectures, respec-
tively. Thus, the only hard prediction that can be drawn
from these allowed kinetic coefficient variations, is that
ADAM12 has to increase kie to accord with the defined
constraints. However this increase remains insufficient to
explain the effect of ADAM12, as no model fits with this
kinetic coefficient variation only.
Another interesting observation is that the amount of
modified kinetic parameters, compared to physiological
models, greatly varies from one ADAM12 model to
another. Following Occam's razor, we considered the
models displaying the fewer modifications. These are
models following V-model architecture. They are charac-
terized by an increased rate of receptor internalization
towards the endosome and a decreased rate of internaliza-
tion towards the caveosome. These modifications could
be explained by a single effect of ADAM12, a redistribu-
tion of TGF-β  receptors at the cell surface membrane,
closer to clathrin pits and farther from caveolae.
ADAM12 induces a permanent response to TGF-β
The constitutive to induced degradation ratio (CIR) char-
acterizes the response type to TGF-β  [9]. Upon TGF-β
stimulation, a low CIR implies a transient response fol-
lowed by an important decrease of the signal. In high CIR
value systems, the decreasing phase tends to disappear
and the signaling output is sustained at high values.
We computed a CIRlike value, which generalizes the CIR
properties, to characterize the reponse type of TGF-β
under the potential effects of ADAM12. It was computed
at the stable state of the models.
For models with V-model architecture:
For models with Z-model architecture:
The CIRlike value is increased in all the solutions (by a fac-
tor 3.93 and 4.43 for V-model and Z-model architectures,
respectively), suggesting that ADAM12 might have an
CIR
kcd LRCm
klid LRCc
like =
∗
∗
CIR
kcd LRCe
klid LRCc
like =
∗
∗
Table 2: Physiological values of kinetic coefficients in V-model and Z-model
V-model Z-model References
pR - Receptors production rate 4 4 [9]
kie - Internalization rate towards endosome 0.1667 0.1667 [5,12]
kre - Recycling rate from endosome 0.0333 0.0333 [12,13]
kic - Internalization rate towards caveosome 0.1667 0.1667 [5,12]
krc - Recycling rate from caveosome 0.0333 0.0333 [12,13]
kcd - Constitutive degradation rate 0.0278 0.0056 [5]
klid - Ligand induced degradation rate 0.05 0.05 [5]
ka - LRC formation rate 1 1 [9]BMC Research Notes 2009, 2:193 http://www.biomedcentral.com/1756-0500/2/193
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effect not only on the strength of the signal, but also on its
shape. As described in Figure 5, the shape of the TGF-β sig-
nal is modified in pathological models when compared to
the physiological ones. Panel A corresponds to V-model
with its nominal parameters (medium CIRlike value) and
represents the amount of LRCs present in the endosome
upon TGF-β stimulation, reflecting TGF-β signaling activ-
ity in physiological condition. Panel B and Panel C repre-
sent the response to TGF-β  of two models handling
ADAM12 (with V-model architecture). Panel B displays a
system where the CIRlike value is almost the lowest we can
find among the solutions, i.e., 5 times the nominal value.
We observe a stronger modification of TGF-β signaling
with increasing CIRlike, as exemplified in Panel C (for
Equations governing V-model and Z-model and diagrammatic representations Figure 1
Equations governing V-model and Z-model and diagrammatic representations. The blue elements represent TGF-
β receptors, the green stars are for TGF-β. Red and purple crosses are for constitutive degradation and ligand induced degra-
dation, repectively. The yellow star stresses LRCs present in the endosomal compartment, standing for TGF-β signal strength. 
Abbreviations are given in table 1.
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Physiological models have similar behavior Figure 2
Physiological models have similar behavior. The evolution of the amount of LRCe present in the endosome (TGF-β 
activity) in V-model (red) and Z-model (green) have comparable trends. TGF-β stimulation begins at time = 100 mn.
Table 3: Biological observations and mathematical translation
Biological observation Mathematical translation
Constraint 1 an increase of R-Smads phosphorylation and an increase of the 
transcription of some SMAD regulated genes is observed upon addition of 
ADAM12 [8]
at stable state, with TGF-β, the amount of LRCs present in the endosome is 
increased by at least a factor 2
Constraint 2 cells transfected with Tβ RII and increasing amounts of ADAM12 proved 
that the more ADAM12 there was, the higher the steady state level of Tβ 
RII was [8]
at stable state, without TGF-β, the total amount of receptors present in the 
system is increased by at least a factor 2
Constraint 3 immunofluorescence studies showed that ADAM12 modifies the ratio of 
the Tβ RII present at the cell surface membrane out of those internalized, 
favoring the intracellular compartments [8]
at stable state, without TGF-β, the ratio of internalized receptors out of 
those present in the membrane is increased by at least a factor 2
Constraint 4 ADAM12 expression decreases the amount of SMAD7 complexed with 
ligand-receptor complexes, and thus their ubiquitination [8]
at stable state, with TGF-β, the ligand induced degradation flow is decreased 
by at least a factor 2
Constraint 5 overexpression studies with ADAM12 and gene reporter assay showed 
that ADAM12 does not maintain transcriptional activity after TGF-β 
removal (unpublished data)
after stabilization with TGF-β, and removal of TGF-β, the amount of LRCs 
present in the endosome becomes negligible within the first 200 minutesBMC Research Notes 2009, 2:193 http://www.biomedcentral.com/1756-0500/2/193
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which we arbitrarily choosed a higher CIRlike value of 30).
Through these examples ADAM12 appears to induce a
sustained strong activation of the TGF-β pathway.
Discussion
ADAM12 is up-regulated during chronic liver injury [6,7]
and modulates TGF-β activity [8], thereby contributing to
TGF-β dependent liver fibrosis. In this work, we fitted dif-
ferential models describing the well documented system
of TGF-β  receptor trafficking to take into account new
observations on the perturbations occurring in presence
of ADAM12. This led us to propose a set of possible mod-
els describing pathological situation. Studying the differ-
ences between the physiological models and the new
ones, provides information about the effect of ADAM12
that could not have been drawn using only experimental
observations.
Based on previous studies [9,10], we first designed differ-
ential models handling TGF-β receptors trafficking among
membranes (V-model and Z-model). The structural differ-
ence between these models is the constitutive degradation
localized at the cell surface membrane in V-model and in
the endosome in Z-model. Constitutive degradation is
Possible models for ADAM12 fit the constraints Figure 3
Possible models for ADAM12 fit the constraints. Comparison between V-model (red) and one of the models handling 
ADAM12 (blue). X-axis represents time in minute. The ADAM12 model has V-model architecture and its kinetic coefficient 
multipliers are: 7.5 kie, 1 kre, 0.15 kic, 1 krc, 1 kcd, 1 klid. Panel A displays the amount of LRCe, the system is stimulated by TGF-β 
from time = 3000 to time = 7000. The amount of LRCe, in the ADAM12 model, is increased and the signal is not persistent 
upon removal of TGF-β (constraints 1 and 5). Panel B displays the total amount of receptors present in the system, without 
TGF-β stimulation. This amount is increased in the ADAM12 model (constraint 2). Panel C displays the ratio of internalized 
receptors out of those in the cell membrane, without TGF-β stimulation. This ratio is increased in the ADAM12 model (con-
straint 3). Panel D displays the product of the amount of LRCe by klid, the system is stimulated by TGF-β from time = 3000 to 
time = 7000. This stands for the flow of LRCe going under ligand induced degradation. This flow is decreased in the ADAM12 
model (constraint 4).BMC Research Notes 2009, 2:193 http://www.biomedcentral.com/1756-0500/2/193
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assumed to occur at the end of the endosomal maturation
process, when internalized receptors go through early
endosome, late endosome and are then degraded in the
lysosome. The hypothesis by Vilar et al. [9] implies that a
sorting mechanism occurs at the cell surface membrane,
separating the elements that will undergo degradation
from those that will be recycled back to the cell surface. As
the endosomal dynamics are still far from being fully
understood, this hypothesis cannot be dismissed, and we
studied the two propositions.
Using a heuristic search, driven by a cost function derived
from qualitative biological data, we defined the set of pos-
sible models handling ADAM12. Those models suggest
that the presence of ADAM12 increases the internalization
rate of TGF-β  receptors between the cell surface mem-
brane and the endosome. An interesting aspect is that
ADAM12 might not only affect TGF-β signaling strength
but also its shape. This comes from the modification of
the ratio between constitutive degradation and ligand
induced degradation (CIRlike), favoring the first one. In
presence of ADAM12, the predicted signaling response to
TGF-β seems like a step increase, maintaining a perma-
nent and high level response replacing the transient com-
ponent of the physiological response. Interestingly, other
signaling pathways were shown to produce different
responses depending on the shape of the input signal. For
instance, a transient activation of the MAPK cascade in
EGF pathaway leads to cell proliferation while a perma-
nent activation leads to cell differentiation [14]. In our
case, ADAM12, which according to our predictions modi-
fies TGF-β signaling, could be partly responsible for the
changes observed in TGF-β signaling during liver fibrosis.
Two-dimensional projections of the solution space Figure 4
Two-dimensional projections of the solution space. In red are the models with V-model architecture, in green, the 
models with Z-model architecture. Units are the kinetic coefficient multipliers of the physiological models. Axis are scaled 
from 0 to 10. Blue lines represent a multiplier of 1 (physiological kinetic coefficients).BMC Research Notes 2009, 2:193 http://www.biomedcentral.com/1756-0500/2/193
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Finally, although many models for the possible effect of
ADAM12 differ from the physiological models by all the
kinetic parameters, it is difficult to imagine that ADAM12
could have such a wide range of action, i.e. changing every
parameter. In fact, some models are a lot more parsimoni-
ous. For instance, a group of them only shows an
increased rate of internalization towards the endosome
and a decreased rate of internalization towards the caveo-
some. Under such assumption, the effect of ADAM12
could be a redistribution of TGF-β receptors in the cell sur-
face membrane closer to clathrine pits and farther from
caveolae. Interestingly, Interleukin-6 (IL-6), an important
regulator of inflammation, has been suggested to simi-
larly decrease the partitioning of TGF-β receptors to the
raft-caveolin membrane fractions while enhancing TGF-β
signaling activity [15].
Taken together, our data give new insights into the role of
ADAM12 in TGF-β signaling. Our models predict that its
impact might contribute to the sustained TGF-β activity
that triggers liver fibrosis.
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